AbstractBrain metastases are highly resistant to chemotherapy. Metastatic tumor cells are known to exploit the host microenvironment for their growth and survival. We report here that melanoma brain metastases are surrounded and infiltrated by activated astrocytes, and we hypothesized that these astrocytes can play a role similar to their established ability to protect neurons from apoptosis. In coculture experiments, astrocytes, but not fibroblasts, reduced apoptosis in human melanoma cells treated with various chemotherapeutic drugs. This chemoprotective effect was dependent on physical contact and gap junctional communication between astrocytes and tumor cells. Moreover, the protective effect of astrocytes resulted from their sequesterin...
<div><p>Clearing of dead cells is a fundamental process to limit tissue damage following brain injur...
Brain metastasis is a defining component of tumor pathophysiology, and the underlying mechanisms res...
Abstract Background In malignant melanoma, it has been published that up to 40% of cancer patients w...
Brain metastases are highly resistant to chemotherapy. Metastatic tumor cells are known to exploit t...
AbstractBrain metastases are highly resistant to chemotherapy. Metastatic tumor cells are known to e...
Brain metastasis is resistant to chemotherapy while the leaky blood-brain-barrier in brain metastasi...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
Malignant melanoma is the deadliest of skin cancers. Melanoma frequently metastasizes to the brain, ...
Tumour metastasis to the brain is a complex process involving crosstalk between the circulating tumo...
Melanoma is the deadliest skin cancer due to its high rate of metastasis, frequently to the brain. B...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
Primary brain neoplasms and metastases to the brain are generally resistant to systemic chemotherapy...
Brain metastasis, the secondary growth of malignant cells within the central nervous system (CNS), e...
BACKGROUND: Gliomas are "intraparenchymally metastatic" tumors, invading the brain in a non-destruct...
<div><p>Clearing of dead cells is a fundamental process to limit tissue damage following brain injur...
Brain metastasis is a defining component of tumor pathophysiology, and the underlying mechanisms res...
Abstract Background In malignant melanoma, it has been published that up to 40% of cancer patients w...
Brain metastases are highly resistant to chemotherapy. Metastatic tumor cells are known to exploit t...
AbstractBrain metastases are highly resistant to chemotherapy. Metastatic tumor cells are known to e...
Brain metastasis is resistant to chemotherapy while the leaky blood-brain-barrier in brain metastasi...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
Malignant melanoma is the deadliest of skin cancers. Melanoma frequently metastasizes to the brain, ...
Tumour metastasis to the brain is a complex process involving crosstalk between the circulating tumo...
Melanoma is the deadliest skin cancer due to its high rate of metastasis, frequently to the brain. B...
In the United States, more than 40% of cancer patients develop brain metastasis. The median survival...
Primary brain neoplasms and metastases to the brain are generally resistant to systemic chemotherapy...
Brain metastasis, the secondary growth of malignant cells within the central nervous system (CNS), e...
BACKGROUND: Gliomas are "intraparenchymally metastatic" tumors, invading the brain in a non-destruct...
<div><p>Clearing of dead cells is a fundamental process to limit tissue damage following brain injur...
Brain metastasis is a defining component of tumor pathophysiology, and the underlying mechanisms res...
Abstract Background In malignant melanoma, it has been published that up to 40% of cancer patients w...